126 related articles for article (PubMed ID: 32507756)
21. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
Le Ber I
Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980
[TBL] [Abstract][Full Text] [Related]
22. Genetic contribution of FUS to frontotemporal lobar degeneration.
Van Langenhove T; van der Zee J; Sleegers K; Engelborghs S; Vandenberghe R; Gijselinck I; Van den Broeck M; Mattheijssens M; Peeters K; De Deyn PP; Cruts M; Van Broeckhoven C
Neurology; 2010 Feb; 74(5):366-71. PubMed ID: 20124201
[TBL] [Abstract][Full Text] [Related]
23. [Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and ataxin-2].
Ito D
Rinsho Shinkeigaku; 2012; 52(11):1221-3. PubMed ID: 23196570
[TBL] [Abstract][Full Text] [Related]
24. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.
Luty AA; Kwok JB; Dobson-Stone C; Loy CT; Coupland KG; Karlström H; Sobow T; Tchorzewska J; Maruszak A; Barcikowska M; Panegyres PK; Zekanowski C; Brooks WS; Williams KL; Blair IP; Mather KA; Sachdev PS; Halliday GM; Schofield PR
Ann Neurol; 2010 Nov; 68(5):639-49. PubMed ID: 21031579
[TBL] [Abstract][Full Text] [Related]
25. Frontotemporal lobar degeneration: new understanding brings new approaches.
Tartaglia MC
Neuroimaging Clin N Am; 2012 Feb; 22(1):83-97, viii. PubMed ID: 22284735
[TBL] [Abstract][Full Text] [Related]
26. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
[TBL] [Abstract][Full Text] [Related]
27. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis.
Mackenzie IR; Neumann M
Brain Res; 2012 Jun; 1462():40-3. PubMed ID: 22261247
[TBL] [Abstract][Full Text] [Related]
28. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis.
Broustal O; Camuzat A; Guillot-Noël L; Guy N; Millecamps S; Deffond D; Lacomblez L; Golfier V; Hannequin D; Salachas F; Camu W; Didic M; Dubois B; Meininger V; Le Ber I; Brice A;
J Alzheimers Dis; 2010; 22(3):765-9. PubMed ID: 21158017
[TBL] [Abstract][Full Text] [Related]
29. [Frontotemporal Lobar Degeneration: A Historical Overview of the Concept].
Kawakatsu S; Kobayashi R; Sakamoto K; Otani K
Brain Nerve; 2020 Jun; 72(6):561-573. PubMed ID: 32507755
[TBL] [Abstract][Full Text] [Related]
30. TDP-43 and FUS: a nuclear affair.
Dormann D; Haass C
Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
[TBL] [Abstract][Full Text] [Related]
32. What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?
Menon R; Baborie A; Jaros E; Mann DM; Ray PS; Larner AJ
J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1412-4. PubMed ID: 21084263
[No Abstract] [Full Text] [Related]
33. Brain perfusion patterns in familial frontotemporal lobar degeneration.
Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
[TBL] [Abstract][Full Text] [Related]
34. Caudate atrophy on MRI is a characteristic feature of FTLD-FUS.
Josephs KA; Whitwell JL; Parisi JE; Petersen RC; Boeve BF; Jack CR; Dickson DW
Eur J Neurol; 2010 Jul; 17(7):969-75. PubMed ID: 20236174
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathways of frontotemporal lobar degeneration.
Sleegers K; Cruts M; Van Broeckhoven C
Annu Rev Neurosci; 2010; 33():71-88. PubMed ID: 20415586
[TBL] [Abstract][Full Text] [Related]
36. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
37. TAR DNA-Binding Protein 43 and Disrupted in Schizophrenia 1 Coaggregation Disrupts Dendritic Local Translation and Mental Function in Frontotemporal Lobar Degeneration.
Endo R; Takashima N; Nekooki-Machida Y; Komi Y; Hui KK; Takao M; Akatsu H; Murayama S; Sawa A; Tanaka M
Biol Psychiatry; 2018 Oct; 84(7):509-521. PubMed ID: 29752072
[TBL] [Abstract][Full Text] [Related]
38. [Progressive nonfluent aphasia].
Murayama S; Saito Y
Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
[TBL] [Abstract][Full Text] [Related]
39. Distinct pathological subtypes of FTLD-FUS.
Mackenzie IR; Munoz DG; Kusaka H; Yokota O; Ishihara K; Roeber S; Kretzschmar HA; Cairns NJ; Neumann M
Acta Neuropathol; 2011 Feb; 121(2):207-18. PubMed ID: 21052700
[TBL] [Abstract][Full Text] [Related]
40. Genetics of FTLD: overview and what else we can expect from genetic studies.
Pottier C; Ravenscroft TA; Sanchez-Contreras M; Rademakers R
J Neurochem; 2016 Aug; 138 Suppl 1():32-53. PubMed ID: 27009575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]